These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23689261)

  • 1. Normal and proton pump inhibitor-mediated gastrin levels in infants 1 to 11 months old.
    Treem W; Hu P; Sloan S
    J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):520-6. PubMed ID: 23689261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of delayed release rabeprazole in 1- to 11-month-old infants with symptomatic GERD.
    Hussain S; Kierkus J; Hu P; Hoffman D; Lekich R; Sloan S; Treem W
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):226-36. PubMed ID: 24121146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A; Wruble LD; Humphries TJ
    Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).
    Akahoshi T; Kawanaka H; Tomikawa M; Saeki H; Uchiyama H; Ikeda T; Shirabe K; Hashizume M; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Dec; 104(12):483-9. PubMed ID: 24693675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.
    Sanduleanu S; Stridsberg M; Jonkers D; Hameeteman W; Biemond I; Lundqvist G; Lamers C; Stockbrügger RW
    Aliment Pharmacol Ther; 1999 Feb; 13(2):145-53. PubMed ID: 10102943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of prolonged treatment with proton pump inhibitors on serum gastrin levels and the fundus mucosa. Preliminary results].
    Cadiot G; Vissuzaine C; Pospai D; Ruszniewski P; Potet F; Mignon M
    Gastroenterol Clin Biol; 1995 Oct; 19(10):811-7. PubMed ID: 8566561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans.
    Raines D; Chester M; Diebold AE; Mamikunian P; Anthony CT; Mamikunian G; Woltering EA
    Pancreas; 2012 May; 41(4):508-11. PubMed ID: 22460728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of proton-pump inhibitor therapy on serum chromogranin a level.
    Pregun I; Herszényi L; Juhász M; Miheller P; Hritz I; Patócs A; Rácz K; Tulassay Z
    Digestion; 2011; 84(1):22-8. PubMed ID: 21304238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies.
    Heilmann RM; Berghoff N; Grützner N; Parnell NK; Suchodolski JS; Steiner JM
    BMC Vet Res; 2017 Nov; 13(1):321. PubMed ID: 29115998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
    Nagahara A; Asaoka D; Hojo M; Oguro M; Shimada Y; Ishikawa D; Osada T; Kawabe M; Yoshizawa T; Otaka M; Watanabe S
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S122-8. PubMed ID: 20586853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
    Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A
    Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebound hypersecretion after inhibition of gastric acid secretion.
    Qvigstad G; Waldum H
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):202-8. PubMed ID: 15125689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration.
    Romero A; Gómez F; Villamayor F; Ballesta A; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):524-7. PubMed ID: 9205757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin].
    Kim BW; Lee BI; Kim HK; Cho YS; Chae HS; Lee HK; Kim HJ; Han SW
    Korean J Gastroenterol; 2009 Feb; 53(2):84-9. PubMed ID: 19237833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin.
    Suzuki T; Kagami T; Uotani T; Yamade M; Hamaya Y; Iwaizumi M; Osawa S; Sugimoto K; Miyajima H; Furuta T
    Eur J Clin Pharmacol; 2018 Jan; 74(1):45-52. PubMed ID: 28986609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.
    Franke A; Hepp C; Harder H; Beglinger C; Singer MV
    Scand J Gastroenterol; 2008; 43(12):1425-31. PubMed ID: 18924018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists.
    Dhillo WS; Jayasena CN; Lewis CJ; Martin NM; Tang KC; Meeran K; Todd JF
    Ann Clin Biochem; 2006 Mar; 43(Pt 2):153-5. PubMed ID: 16536918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.